Theseus Pharmaceuticals Story
| THRXDelisted Stock | USD 4.06 0.00 0.00% |
Slightly above 56% of Theseus Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Theseus Pharmaceuticals suggests that many traders are alarmed regarding Theseus Pharmaceuticals' prospects. Theseus Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Theseus Pharmaceuticals. The current market sentiment, together with Theseus Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Theseus Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Theseus Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Theseus daily returns and investor perception about the current price of Theseus Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Theseus |
Requested story not found. it has been either deleted or moved. View all stories for Theseus Pharmaceuticals.
Theseus Pharmaceuticals Latest Timeline
Theseus Pharmaceuticals is listed for 4.06. About 93.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.81. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Theseus Pharmaceuticals has Price/Earnings (P/E) ratio of 737.67. The entity recorded a loss per share of 1.34. The firm last dividend was issued on the September 8, 2015. Theseus Pharmaceuticals had 1241:1000 split on the June 3, 2014.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |